Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00576719 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia

A Phase 2 study, sponsored by Boston University.

Completed
Registry status
Phase 2
Development phase
63
Enrollment target

NCT00576719 is a Phase 2 study that has completed, run by Boston University. The registered enrollment target is 63 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00576719, a Phase 2 study, has completed, sponsored by Boston University.

COMPLETED
Registry status
Phase 2
Development phase
63 participants
Enrollment target

Study Summary

This study will evaluate the effectiveness of intensive cognitive behavioral therapy in treating adolescents with panic disorder with agoraphobia.

Interventions

  • OTHER Waitlist control
  • BEHAVIORAL Intensive panic control treatment without parent involvement
  • BEHAVIORAL Intensive panic control treatment with parent involvement

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2005-03
Est. Completion 2011-03
Phase Phase 2

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT00576719

The ClinicalTrials.gov registry entry for NCT00576719 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Waitlist control is the first listed.

NCT00576719 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00576719 about?

NCT00576719 is a clinical study titled "Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia". This study will evaluate the effectiveness of intensive cognitive behavioral therapy in treating adolescents with panic disorder with agoraphobia.

What is the current status of trial NCT00576719?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 63 participants. The study started on 2005-03. Estimated completion is 2011-03.

What interventions are being tested in trial NCT00576719?

The interventions under investigation include: Waitlist control (OTHER), Intensive panic control treatment without parent involvement (BEHAVIORAL), Intensive panic control treatment with parent involvement (BEHAVIORAL).

Who is sponsoring clinical trial NCT00576719?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.